Anavex Life Sciences Corp. (AVXL) vs Protalix BioTherapeutics, Inc. (PLX)
Anavex Life Sciences Corp. and Protalix BioTherapeutics, Inc. are both Biotechnology companies. Anavex Life Sciences Corp. and Protalix BioTherapeutics, Inc. are of similar size ($221.6M and $216.9M). Anavex Life Sciences Corp. has negative trailing earnings, so its P/E is not meaningful; Protalix BioTherapeutics, Inc. trades at 11.3×. Protalix BioTherapeutics, Inc. has the higher net margin (23.5% vs 0.00%) and the higher return on invested capital (48.5% vs 0.00%). Across the 12 metrics below, Protalix BioTherapeutics, Inc. leads on 8 and Anavex Life Sciences Corp. on 4.
Valuation
Profitability
| Metric | AVXL | PLX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 69.20% | 65.16% |
| Operating margin | 0.00% | 28.89% | 0.00% |
| Net margin | 0.00% | 23.50% | 0.00% |
| Free cash flow margin | 0.00% | 9.51% | 0.00% |
| Return on equity | (12.80%) | 31.23% | (57.72%) |
| Return on assets | (11.70%) | 20.07% | (49.22%) |
| Return on invested capital | 0.00% | 48.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack